Market Tracker

06/24 5:16pm ET

Dr.Reddy's Laboratories Ltd (NYSE:RDY)

47.24
Delayed Data
As of Jun 24
 -0.74 / -1.54%
Today’s Change
40.67
Today|||52-Week Range
68.00
+2.05%
Year-to-Date
What Exactly Did Allergan and Teva Sell to Impax?
Jun 21 / TheStreet.com - Paid Partner Content
3 High-Growth Stocks You Don't Need to Babysit
Jun 17 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close47.98
Today’s open46.68
Day’s range46.68 - 47.64
Volume702,955
Average volume (3 months)321,637
Market cap$8.1B
Dividend yield0.66%
Data as of 4:02pm ET, 06/24/2016

Growth & Valuation

Earnings growth (last year)-15.85%
Earnings growth (this year)--
Earnings growth (next 5 years)+7.14%
Revenue growth (last year)-2.51%
P/E ratio0.3
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
IDXXIDEXX Laboratories I...-3.91-4.27%
JAZZJazz Pharmaceuticals...-7.10-4.90%
VRXValeant Pharmaceutic...-1.98-8.90%
MDVNMedivation Inc-2.31-3.90%
Data as of 4:02pm ET, 06/24/2016

Financials

Next reporting dateJuly 20, 2016
EPS forecast (this quarter)$0.47
Annual revenue (last year)$2.4B
Annual profit (last year)$305.0M
Net profit margin12.94%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Co-Chairman, Chief Executive Officer &
MD
Gunupati Venkateswara Prasad
President, CFO &
Global Head-IT
Saumen Chakraborty
Corporate headquarters
Hyderabad, Telangana

Forecasts